MiniMed Go system

Worry less about figuring out the right correction dose with the only smart MDI system that continuously monitors, notifies you when a dose is needed, and calculates the suggested correction dose.1​



Good to go for ages 2 and up.

 

MiniMed Go system

Remembers. Reminds. Recommends. 
So you don’t have to.


Proper pairing, connectivity, and settings required or incorrect dosing and serious injury can occur. Ages 2-6 require caregiver supervision. See user guide for full details.

Remembers your insulin doses
Automatically logs doses on your smartphone so there's less to keep track of.
 

Reminds you when more insulin is needed
Alerts you when you need more insulin to help keep your levels in range.
 

Recommends smart actions
Uses your glucose and active insulin levels to determine if you need a dose, and tells you how much to take.
 

Pay as little as $185

Simplify your start on the MiniMed Go system.

Get the InPen smart insulin pen for as little as $125 and the Instinct sensor, made by Abbott, for as low as $60 — that’s $185 for the whole system! Terms and conditions apply. 

Meet the MiniMed Go system

InPen smart insulin pen

Add icon collapse icon

A reusable smart insulin pen that sends data to the MiniMed Go app, automating insulin dose tracking. Offers half-unit dosing. Comes in 3 color options: blue, gray, and pink.

inpen amimation

Instinct sensor, made by Abbott

Add icon collapse icon

Instinct sensor is small, discreet2 and comfortable3 to wear with one-hour warm-up period.

Instinct sensor

MiniMed Go app

Add icon collapse icon

Integrates real-time glucose (CGM) monitoring, insulin dose tracking, and dose calculations and logging in a single app.3 Easily share reports with your healthcare provider. Check app compatibility.

 

 

MiniMed Go app

Simple set up. Seamless start.

All your onboarding happens in the MiniMed Go app, so you can get started when it's convenient for you.

After you're on therapy, we offer 24/7 support when you need it.

Tech specs

Indications for use

For people with diabetes.

  • InPen: All ages, ages 2–6 require adult caregiver supervision.
  • Instinct sensor: All ages, ages 2–6 require adult caregiver supervision.
  • Simplera sensor: 18 years and over

Connectivity

  • InPen to app: Bluetooth® Low Energy (BLE) and Near Field Communications (NFC)
  • Sensors to app: Bluetooth® Low Energy (BLE) v4.2, 2.402–2.480 GHz, GFSK modulation, minimum 20 ft (6.09 m) line-of-sight range

Alert ranges

Instinct sensor

  • ≤ 55 mg/dL. Always active; cannot be disabled or adjusted.
  • Low alert limit range: 60–100 mg/dL (user-adjustable)
  • High alert limit range: 120–400 mg/dL (user-adjustable)
     

Simplera sensor


  • Urgent low glucose alert: ≤ 64 mg/dL. Always active; cannot be disabled or adjusted
  • Low alert limit range: 65–90 mg/dL (user-adjustable)
  • High alert limit range: 100–400 mg/dL (user-adjustable)
  • Alert before low: Up to 60 minutes before predicted low; adjustable down to 10 minutes
  • Alert before high: Adjustable lead time
  • Low glucose alert detection rate: 94.7% correct detection rate; 5.3% missed detection rate (≤70 mg/dL, 30-minute detection window, arm insertion, adults)
  • High glucose alert detection rate: 98.6% correct detection rate; 1.4% missed detection rate (≥180 mg/dL, 30-minute detection window, arm insertion, adults)

Compatible insulin

The MiniMed Go system is intended for use with the following compatible U-100 insulins:

• U-100 HumalogTM*
• U-100 NovoLogTM*
• U-100 FiaspTM*

Battery

The InPen is a reusable device with a non-replaceable battery designed to last for one year, after which it must be replaced.

Warranty

InPen: One year

Frequently asked questions

Add icon collapse icon

What is the MiniMed Go system?

Add icon collapse icon

The MiniMed Go system is a diabetes management system combining the InPenTM smart insulin pen, a compatible continuous glucose monitor, and the MiniMed Go mobile app. Together, these technologies help you deliver the right dose at the right time.

Who can use MiniMed Go?

Add icon collapse icon

When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. 

Can I use another company’s CGM with this system?

Add icon collapse icon

No, the only compatible sensors for the MiniMed Go system are the Simplera sensor and Instinct sensor.

How close does the app need to be to the insulin pen to not lose connection?

Add icon collapse icon

For pairing, the InPen must be within 3 feet (1 meter) of the MiniMed Go app. The InPen does not need to stay within range of the MiniMed Go app unless a dose is being administered. The pen and app must be within 3 feet (1 meter) for data to be sent. 

 

Make sure the MiniMed Go app and the sensor are located within 20 feet to ensure glucose data is being communicated.

What’s the difference between MiniMed Flex and MiniMed Go?

Add icon collapse icon

MiniMed Flex is an automated insulin delivery system that uses an insulin pump. MiniMed Go is a smart multiple daily injection system.

How long is the warranty?

Add icon collapse icon

MiniMed warrants the InPen smart insulin pen against defects in materials and workmanship for a period of 1 year from the date of purchase. 

Can I get MiniMed Go if I do not have a compatible smartphone?

Add icon collapse icon

If you don’t have a compatible smartphone, we can provide an App Manager — a separate device that gives you access to the MiniMed Go app.

Footnote
† Age indication: When used with the Instinct sensor, the app is indicated for patients 7+ years; for ages 2–6, use under adult caregiver supervision. When used with Simplera CGM, the app is indicated for patients ages 18 and over.

References

  1. Proper pairing, connectivity, and settings required. Talk to your healthcare professional before establishing and changing your settings. Ensure that all doses taken with InPen are logged in the app, that all doses taken with a device other than InPen are logged manually in the app, and that glucose and meal information entered into the dose calculator are current and accurate. Not doing so can result in incorrect dosing, hypoglycemia or hyperglycemia, and serious injury.
  2. Data on file, Abbott Diabetes Care, Inc.​​
  3. Alva, Shridhara, Ronald Brazg, Kristin Castorino, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. "Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System." Diabetes Therapy 14, no. 4 (2023): 767-776. https://doi.org/10.1007/s13300-023-01385-6

InPen Copay Program terms and conditions

  • Open to insured patients and patients with commercial prescription insurance and those who are not enrolled in any government-funded program that pays for prescription devices or treatments.
  • Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE® that provides coverage for InPen, or where prohibited by law.
  • Cash Discount Cards and other non-insurance plans are not valid as primary under this offer.
  • Offer subject to change or discontinue without notice. This is not health insurance.
  • Offer applies to a maximum of 1 prescribed InPen per Patient per benefit year.
  • Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics.

Important safety information: MiniMed Go system

The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see https://bit.ly/MiniMedRisks.